Literature DB >> 23524037

Re: "Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study".

Holly Janes, Margaret Pepe.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23524037      PMCID： PMC3668426          DOI： 10.1093/aje/kwt043

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  7 in total

1.  Therapeutic decision making: a cost-benefit analysis.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

2.  Putting risk prediction in perspective: relative utility curves.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2009-10-20       Impact factor: 13.506

3.  Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance.

Authors:  Ralph B D'Agostino; Michael J Pencina
Journal:  Am J Epidemiol       Date:  2012-07-19       Impact factor: 4.897

4.  Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study.

Authors:  Davood Khalili; Farzad Hadaegh; Hamid Soori; Ewout W Steyerberg; Mohammadreza Bozorgmanesh; Fereidoun Azizi
Journal:  Am J Epidemiol       Date:  2012-07-19       Impact factor: 4.897

5.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

6.  Using relative utility curves to evaluate risk prediction.

Authors:  Stuart G Baker; Nancy R Cook; Andrew Vickers; Barnett S Kramer
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-10-01       Impact factor: 2.483

7.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.